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Aims: Non-alcohol fatty liver disease (NAFLD) is a strong risk factor for insulin resistance
and type 2 diabetes. The prevalence of NAFLD varies across populations of different ethnic
backgrounds but the prevalence in Middle Eastern populations, which are at high risk of type
2 diabetes, is largely unknown. Using fatty liver index (FLI) as a proxy for NAFLD the aim was
to calculate the odds of NAFLD (FLI  70) given country of origin and further to investigate
the associations between ISI and FLI.
Methods: In 2010–2012 we conducted a population-based study of individuals aged 30–75
years born in Iraq or Sweden, in whom anthropometrics, fasting blood samples and oral
glucose tolerance tests were performed and sociodemography and lifestyle behaviors
characterized.
Results: A higher proportion of Iraqis (N = 1085) than Swedes (N = 605) had a high probability
of NAFLD (FLI  70, 32.5 vs. 22.6%, p < 0.001, age- and sex-adjusted data) and ISI was more
severely impaired (70.7 vs. 95.9%, p < 0.001). Independently of traditional risk factors for
NAFLD, being born in Iraqi increased the risk of FLI  70 (OR 1.59: 95% CI 1.15, 2.20).
Furthermore, country of birth presented a stronger association between ISI and FLI  70
in Iraqis than in Swedes (Pinteraction = 0.019).
Conclusions: Our data indicate that immigrants from Iraq are at higher risk of NAFLD. The
finding that country of birth modifies the relationship of FLI with ISI, suggests that liver fat
may be a stronger determinant of impaired insulin action and increased risk of type 2
diabetes in Iraqis than in Swedes.
# 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
* Corresponding author at: Center for Primary Health Care Research, Clinical Research Centre, Building 28, Floor 11, Jan Waldenstro¨ms
gata 35, Ska˚ne University Hospital, 205 02 Malmo¨, Sweden. Tel.: +46 40 391367; fax: +46 40 391370.
E-mail address: Louise.Bennet@med.lu.se (L. Bennet).
Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; CIR, corrected insulin response; DIo, disposition
index; GGT, gamma-glutamyl transferase; HDL, high-density lipoprotein; IQR, interquartile range; ISI, insulin sensitivity index; LDL, low-
density lipoprotein; p, plasma; SD, standard deviation; TGs, triglycerides.
Contents available at ScienceDirect
Diabetes Research
and Clinical Practice
journal homepage: www.elsevier .com/locate/diabreshttp://dx.doi.org/10.1016/j.diabres.2015.07.011
0168-8227/# 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
d i a b e t e s r e s e a r c h a n d c l i n i c a l p r a c t i c e 1 1 0 ( 2 0 1 5 ) 6 6 – 7 4 671. Introduction
Immigrants from the Middle East represent the largest non-
European immigrant group to Sweden and are, compared to the
native Swedish population, at high risk of impaired insulin
action and type 2 diabetes [1]. The higher prevalence is partly
explained by an excess prevalence of abdominal obesity and
family history of diabetes; nonetheless, our data has shown that
being born in Iraqi is an independent risk factor for diabetes [2].
Furthermore, the MEDIM (impact of Migration and Ethnicity on
Diabetes in Malmo¨) study has shown that insulin sensitivity
index (ISI) is lower in Iraqis than in Swedes, and that ISI may
have a stronger impact on type 2 diabetes risk in Iraqis than in
Swedes [1]. The lower ISI values in immigrants from Iraq are not
fully explained by traditional risk factors such as family history
of diabetes, abdominal obesity or physical inactivity, as
illustrated by the fact that in individuals with a normal waist
circumference and/or body mass index (BMI), ISI is more
impaired than in Iraqis than in Swedes with equivalent levels of
adiposity [1]. This suggests that mechanisms other than
abdominal obesity or other traditional risk factors for insulin
resistance may influence insulin action in Iraqis.
The mechanisms underlying the profound insulin resis-
tance in the Iraqi born population are poorly understood, which
motivated the current study. Whilst insulin action is influenced
by abdominal and visceral obesity, other organs such as
peripheral muscle and the liver are also involved [3]. For
instance, non-alcohol fatty liver disease (NAFLD) represents a
strong risk factor for impaired insulin action, pre-diabetes and
type 2 diabetes [4]. Patients diagnosed with NAFLD also have a
higher release of inflammatory markers than patients without
NAFLD [5] and they also have a higher risk of cardiovascular
disease (CVD) [6]. These results are in consistency with previous
findings from the MEDIM study, showing that the association
between lower ISI and inflammatory markers – such as
cytokines – irrespective of other risk factors [7] is stronger
and that the prevalence of CVD in diabetics is higher in Iraqis
than in Swedes [8]. Altogether these findings indicate that
NAFLD may be more prevalent and have a greater impact on
insulin action and diabetes risk in Iraqis than native Swedes.
Globally, NAFLD is the most prevalent type of liver disease
[9–11] and its prevalence differs according to ethnic background
[12], with 12 to 15% in Asians [13] and 30% in Americans [14]
affected. Although the characteristics of the Iraqi immigrant
population resemble those of patients with NAFLD, the
prevalence of NAFLD and association with insulin action in
Middle Eastern populations has to the best of our knowledge not
been investigated before. Thus, using the fatty liver index (FLI)
as a proxy for NAFLD [15], in the MEDIM study we determined
whether FLI levels differed between immigrants from Iraq and
native Swedes and sought to characterize the factors underly-
ing these differences. Further, we sought to study associations
between insulin sensitivity index (ISI) and FLI.
2. Subjects
Citizens of Malmo¨ born in Iraq and aged 30 to 75 years were
randomly selected from the census register and invited bymail and phone to participate in a population-based survey.
According to the census register, the population of Iraqi
immigrants 30 to 75 years of age in Malmo¨ consisted in 2010 of
4397 persons with a mean age of 44.8 years and of whom 57.8%
were men. Swedish born citizens living in the same geograph-
ical area in Malmo¨ were randomly selected from the census
register to reach a similar age and gender distribution as the
Iraqi population (mean age 45.2 years, p = 0.08; 57.4% males
p = 0.74). Iraqi and Swedish individuals were then contacted
and invited by mail and phone to participate in the study. We
aimed to recruit a final sample of 2:1 Iraqi and Swedish
participants with the goal to reach a similar age and sex
distribution amongst the final participants as amongst the
original background population. People with type 1 diabetes,
severe physical or mental illness or disabilities were excluded
from the study. A prerequisite for inclusion in the study was
also that all values included in the FLI (gamma-glutamyl
transferase (p-GGT), BMI, waist circumference and/or plasma
triglycerides (p-TG)) were assessed.
To minimize cohort effects and assessment biases,
examinations were conducted within a relatively short time-
frame (February 1, 2010 through December 31, 2012). A flow
chart describing the recruitment and participation rate of
MEDIM is presented in a supplementary figure. All participants
conducting an oral glucose tolerance test (OGTT) that did not
have excessive alcohol habits (<9 standard glasses/week for
women and <14 standard glasses/week for men) were
included in the study.
3. Materials and methods
3.1. Physical examination
Standard physical examinations were performed by trained
Swedish- and Arabic-speaking research nurses and clinical
variables such as blood pressure, height, weight, waist
circumferences, BMI and abdominal obesity were assessed
and defined as previously described [16,17].
3.2. Blood samples and oral glucose tolerance tests
Participants were instructed to be fasting and not to eat or
drink anything but water and not to use tobacco after 10 pm
the day before testing. In the following morning, fasting blood
samples were taken and a 75-g OGTT was performed and
blood samples for plasma glucose and serum insulin at 30, 60,
90 and 120 min were collected thereafter. Blood glucose,
serum insulin, HbA1c, total cholesterol, p-TG, high-density
lipoprotein cholesterol (p-HDL) and low-density-lipoprotein
cholesterol (p-LDL) levels were determined as previously
described [16,18]. Plasma alanine aminotransferase (p-ALT,
IU/L), aspartate aminotransferase (p-AST, IU/L) and gamma-
glutamyl transferase (GGT, IU/L) were measured using a Cobas
analyzer (Roche Diagnostics, Mannheim, Germany).
Normal glucose tolerance (NGT), impaired fasting glucose
(IFG), impaired glucose tolerance (IGT), impaired glucose
regulation (IGR, IFG in combination with IGT) and type 2
diabetes were defined according to World Health Organization
criteria [19]; NGT, fasting glucose level of <6.1 mmol/L and a
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glucose level of 6.1 mmol/L and <7.0 mmol/L and a 2-h
plasma glucose level of <7.8 mmol/L, IGT, fasting plasma
glucose level of <6.1 mmol/L and a 2-h plasma glucose level of
7.8 mmol/L and <11.1 mmol/L and type 2 diabetes fasting
plasma glucose level of 7.0 mmol/L and/or a 2-h plasma
glucose level of 11.1 mmol/L. If only one glucose value was
pathologic, the OGTT was repeated on another day within 2
weeks with the same fasting procedures. Two values exceed-
ing these thresholds were needed for diagnosis [19]. IFG, IGT
and IGR are in this paper collectively referred to as ‘prediabe-
tes’. Estimation of insulin sensitivity (ISI) and beta cell
function (corrected insulin response, CIR and oral disposition
index, DIo) were assessed using the Matsuda indices calculat-
ed from the OGTT as described previously [20–23].
FLI was calculated as previously described by Balkau et al.
[15]:
FLI ¼ e
L
ð1 þ eLÞ  100
where L = 0.953 (loge p-TG) + 0.139  BMI + 0.718 (loge
(GGT) + 0.053  waist circumference  15.745.
Liver fat score was calculated as previously described by
Kotronen et al. [24]:
Liver fat score = 2.89 + 1.18  metabolic syndrome
[17](yes = 1/no = 0) + 0.45  type 2 diabetes (yes = 2/no = 0) +
0.15  fasting S-insulin (mU/L) + 0.04  fasting S-AST (U/
L)  0.94  AST/ALT
3.3. Questionnaires
Information on previous diagnoses of diabetes, current
medication, family history of diabetes (in biological parents
and/or siblings), lifestyle habits and sociodemography was
collected in interviews by Arabic- and Swedish-speaking
nurses using structured questionnaires in Swedish and
Arabic. Questionnaires were translated and back-translated
by two independent professional translators with Arabic as
their native language [16].
Smoking habits, alcohol consumption and hours physically
active/week were assessed as described previously [1].
3.4. Statistical analysis
Analyses were performed using STATA IC/12.1. Least squares
means were derived after age and sex adjustment using general
linear models; differences in proportions were adjusted for age
and sex using logistic regression. Associations with FLI 70%
were assessed using stepwise logistic regression analysis and
associations with ISI (log transformed) were assessed by linear
regression analysis. Units were standardized in strata of
ethnicity and sex per 1 standard deviation (SD) unit variance
for the continuous independent variables. Data are expressed
as odds ratios (ORs) (FLI as the dependent variable) and b
coefficients (ISI as the dependent variable) with 95% confidence
intervals (CIs) (Tables 2a and 2b). All tests were two-sided and a
p-value of <0.05 was considered statistically significant.
In order to minimize the multiple testing burden, interac-
tions were considered only when the included marginal
effects were significant.Multicollinearity was not considered an issue, as variance
inflation factor (VIF) values in the final multivariate regression
models were <3.1.
3.5. Ethical considerations
All participants provided written informed consent and the
Ethics Committee at Lund University approved the study
(application nos. 2009/36 and 2010/561). The MEDIM study
conforms to the principles outlined in the Declaration of
Helsinki [25].
4. Results
In total, 1085 participants born in Iraq and 605 participants
born in Sweden were included in the study. Despite the Iraqi as
compared to the Swedish population was younger than the
Swedish population (45.2 vs. 49.1 years, p < 0.001) their FLI
values were higher (54.6 vs. 43.2, p < 0.001) and their insulin
sensitivity was more impaired (ISI 70.7 vs. 95.9%, p < 0.001). A
higher proportion of Iraqis than Swedes had a high probability
of fatty liver (FLI  70, 32.5 vs. 22.6%, p < 0.001, age- and sex-
adjusted data, Fig. 1).
Amongst participants with a high probability of NAFLD
(FLI  70), the Iraqis were paradoxically younger, had lower
total cholesterol levels and lower p-LDL levels as compared to
the Swedes. Furthermore, their prevalence of the metabolic
syndrome was lower and in women waist circumference was
smaller than in Swedes (Table 1). In participants with low
(FLI < 20) and medium FLI values (FLI 20–69), Iraqis had worse
glucose and lipid metabolism, as indicated by lower ISI values,
higher BMI, lower p-HDL levels, higher p-TG levels and higher
fasting glucose levels (Table 1).
In a stepwise logistic regression model we studied risk
factors associated with FLI  70 (Table 2a). Adjusting for the
confounding effect of other known risk factors for NAFLD such
as age, sex, abdominal obesity, type 2 diabetes and/or alcohol
consumption, being born in Iraq remained an independent
risk factor for FLI  70. Other risk factors independently
contributing to higher odds of FLI  70 were female sex, type
2 diabetes and last but not least abdominal obesity that
contributed with over 27 times the odds of FLI  70. Together,
all risk factors explained 34% of the variance (R2) in liver fat
scores (Table 2a). The variance did not differ between
ethnicities (data not shown).
Correlation between FLI and ISI (log-transformed) in
participants without abdominal obesity who were born in
Iraq or Sweden are presented in Fig. 2. This figure shows that
with decreasing ISI, FLI increased even more in Iraqis than in
Swedes, indicating a stronger influence of NAFLD on insulin
resistance in the Iraqi population. We then analysed associa-
tions between ISI and traditional risk factors for insulin
resistance after adjusting for FLI (Table 2b). Being born in Iraq
remained an independent risk factor for impaired ISI in the full
multivariate model. Furthermore, we observed that country of
birth modified the effect of FLI  70 (Pinteraction = 0.019),
indicating a stronger association between ISI and FLI  70%
in Iraqis than in Swedes. Together, all risk factors explained
35% of the variance (R2) in ISI.
Fig. 1 – Distribution of low (<20), medium (20–69) and high (I70) fatty liver index (FLI) values in participants born in Iraq or
Sweden. High FLI values were more prevalent in Iraqis than in Swedes (32.5 vs. 22.6%, p < 0.001), whereas low FLI values
were less prevalent (13.9 vs. 28.7%, p < 0.001).
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In immigrants from Iraq the age and sex distribution did not
differ in study participants compared to the eligible back-
ground population. Participants born in Sweden were older
(49.1 vs. 44.8 years, p < 0.001), but the sex distribution did not
differ compared to the eligible native Swedish population
(data not shown).
5. Discussion
A key novel finding from this study is that irrespective of other
traditional risk factors for fatty liver disease, Iraqis had a
higher risk of NAFLD (FLI  70) than native Swedes. Further-
more, high FLI and Iraqi origin were independently associated
with impaired insulin action irrespective of traditional risk
factors such as physical inactivity, abdominal obesity and type
2 diabetes.
The finding that country of birth modifies the relation-
ship of FLI with ISI, suggests a stronger effect of fatty liver
on insulin action in Iraqis than in Swedes, and opens a
possible effect of fatty liver as a strong contributor to
impaired insulin action and increased risk of type 2 diabetes
in this population that to our knowledge has not been
reported before.
5.1. NAFLD and insulin resistance
Diminished insulin secretion and action are important
pathological determinants of type 2 diabetes [26]. Insulin
action is not only regulated by abdominal or visceral obesity
but that other organs and tissues, such as peripheral muscle
and the liver are also involved [3]. NAFLD is associated with
impaired insulin action and was previously identified as an
independent risk factor for pre-diabetes and type 2 diabetes[3,4]. Previous data from the MEDIM study showed stronger
associations between type 2 diabetes and insulin action in
Iraqis than in Swedes, indicating that in Iraqis impaired
insulin action appears to have a greater impact on type 2
diabetes [1].
The metabolic characteristics of the Iraqi participants in
the MEDIM study resemble a NAFLD phenotype [19–21], with
pronounced insulin resistance, high plasma TG levels and a
high prevalence of diabetes despite less abdominal obesity
[1]. Further, patients diagnosed with NAFLD are reported to
have a higher release of inflammatory markers than patients
without NAFLD [5]. Consistent with those findings, we
previously showed that the associations between lower ISI
and inflammatory markers such as cytokines are stronger in
Iraqis than in Swedes, irrespective of other risk factors [7]. We
have also shown that the association between cardiovascular
disease (CVD) in Iraqis depends on diabetes status, with
three-fold higher odds of CVD in Iraqis with diabetes as
compared Swedes with diabetes; amongst individuals with-
out diabetes the odds of CVD amongst Iraqis half that
observed in Swedes [8]. This is consistent with a previous
study of diabetes patients which reported that patients
diagnosed with NAFLD having a higher prevalence of CVD
than those without NAFLD [6]. Since these data altogether
indicate that a high proportion of the Iraqi population may
have NAFLD in this study we investigated whether differ-
ences in NAFLD could explain the profound insulin resistance
in the Iraqi born group. As a proxy for NAFLD we included
FLI  70 in our analysis. By doing that the variance increased
more than three-fold (from 0.13 to 0.34), reflecting the strong
influence of NAFLD on insulin resistance. Still being born in
Iraq remained an independent risk factor for ethnic differ-
ences in insulin resistance indicating there are additional
genetic-, behavioral or metabolic risk factors influencing
insulin resistance in this immigrant population that remain
to be detected.
Table 1 – Characteristics of the study population born in Iraq or Sweden that underwent an oral glucose tolerance test in relation to low (<20), medium (20–69) or high (I70)
fatty liver index values [15].
Variable Fatty liver index <20 Fatty liver index 20–69 Fatty liver index 70
Born in
Iraq
N = 168 (13.9%)
Born in Sweden
N = 188 (28.7%)
p Born in
Iraq
N = 524 (43.3%)
Born in Sweden
N = 269 (41.1%)
p Born in
Iraq
N = 393 (32.5%)
Born in Sweden
N = 148 (22.6%)
p
Age (years) 41.9 (9.0) 46.8 (10.7) <0.001 45.7 (9.4) 49.4 (11.1) <0.001 46.2 (8.5) 50.6 (11.3) <0.001
Male gender, n (%) 50 (29.8) 63 (33.5) 0.448 299 (57.1) 162 (60.2) 0.393 296 (75.3) 104 (70.3) 0.234
BMI (kg/m2) 24.6 (2.2) 23.2 (2.2) <0.001 27.8 (2.6) 27.0 (2.7) <0.001 32.4 (4.1) 32.3 (4.3) 0.419
Waist men (cm) 85.3 (4.9) 84.1 (7.4) 0.329 93.9 (6.2) 94.9 (6.4) 0.301 105.9 (9.1) 107.7 (8.9) 0.231
Waist women (cm) 81.4 (6.6) 78.6 (7.1) 0.005 92.1 (5.9) 93.0 (6.6) 0.219 103.9 (7.6) 109.9 (9.9) <0.001
ISIa (mmol/L  mU/L1) 121.8
(97.8–161.0)
157.9
(112.2–211.8)
<0.001 83.2
(59.8–18.3)
94.1
(72.1–133.9)
<0.001 53.2
(37.0–74.8)
56.2
(43.0–76.7)
0.177
CIRa
(mU/L  mmol/L1  mmol/L1)
150.8
(95.0–252.8)
130.8
(76.5–204.9)
0.135 164.4
(92.7–267.8)
146.0
(86.9–214.5)
0.973 199.8
(116.8–347.3)
180.9
(111.1–289.4)
0.399
DIoa 19021.9
10605.3–33537.2)
20263.8
(12719.3–30.958.4)
0.221 12879.6
(7302.2–23703.2)
13689.1
(7934.4–24145.3)
0.010 10454.7
(5522–18235)
9801.3
(5186.2–17701.5)
0.834
Total cholesterol (mmol/L) 4.4 (0.8) 4.9 (1.0) <0.001 4.8 (0.9) 5.3 (1.0) <0.001 5.2 (1.0) 5.5 (1.1) 0.001
p-LDL (mmol/L) 2.8 (0.7) 3.0 (0.8) 0.110 3.2 (0.8) 3.4 (0.9) 0.023 3.4 (0.9) 3.7 (1.0) 0.007
p-HDL (mmol/L) 1.4 (0.3) 1.7 (0.4) <0.001 1.2 (0.3) 1.4 (0.4) <0.001 1.1 (0.3) 1.1 (0.3) 0.728
p-TGs (mmol/L) 0.8 (0.3) 0.7 (0.2) 0.008 1.3 (0.6) 1.2 (0.5) <0.001 2.2 (1.2) 2.0 (1.1) 0.551
p-ALT (IU/L) 9.3 (3.3) 8.9 (3.2) 0.573 11.3 (4.9) 12.5 (8.5) 0.011 14.5 (9.1) 13.7 (7.9) 0.879
p-AST (IU/L) 22.9 (6.0) 23.7 (6.3) 0.491 25.9 (6.6) 27.4 (12.1) 0.027 29.8 (10.3) 29.0 (9.4) 0.386
p-GGT (IU/L) 13.9 (7.3) 16.4 (9.4) 0.125 27.7 (16.9) 32.3 (32.0) 0.019 54.0 (52.6) 59.8 (63.3) 0.210
Fasting glucose (mmol/L) 5.5 (0.6) 5.4 (0.5) 0.024 5.7 (0.6) 5.6 (0.6) 0.051 5.6 (0.8) 5.8 (1.0) 0.382
2-h glucose (mmol/L) 5.5 (1.6) 5.4 (1.6) 0.274 5.8 (1.9) 5.6 (1.9) 0.052 6.3 (2.5) 6.6 (2.6) 0.742
Liver fat score [24] 3.5 (1.1) 3.8 (1.1) 0.051 2.2 (1.5) 2.4 (1.3) 0.134 0.6 (1.9) 0.6 (2.1) 0.598
New cases of type 2
diabetes, n (%)
0 0 0.314 10 (1.9) 2 (0.7) 0.220 16 (4.1) 6 (4.1) 0.947
Metabolic syndrome [17], n (%) 19 (11.3) 12 (6.4) 0.066 213 (40.6) 101 (37.5) 0.022 294 (74.8) 125 (84.5) 0.036
Participants with excessive alcohol consumption (9 standard glasses/week in women and 14 standard glasses/week in men) were excluded from the study. Data are presented as the mean
(standard deviation, SD), number (percentage) or median (interquartile range, IQR). Differences in means between groups were adjusted for age and sex using general linear models (for continuous
variables) while differences in proportions between groups were studied using logistic regression adjusted for age and gender. All tests were two-sided and a p-value of <0.05 was considered
statistically significant.
a Data presented as IQR CIR and DIo only included cases where the glucose level at 30 min was >4.44 mmol/L and was greater than the fasting glucose level [22].
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Table 2a – Risk factors associated with fatty liver index
I70% in the total study population.
Variable Model 1
(R2 = 0.09)
OR
95% CI
Model 2
(R2 = 0.10)
OR
95% CI
Model 3
(R2 = 0.34)
OR
95% CI
Born in Sweden
Born in Iraq
Reference
1.73
1.38 to 2.18
Reference
1.71
1.36 to 2.16
Reference
1.59
1.15 to 2.20
Age (years), per 1 SD 1.16
1.04 to 1.30
1.14
1.02 to 1.28
1.02
0.90 to 1.15
Female sex
Male sex
Reference
2.84
2.26 to 3.56
Reference
2.85
2.27 to 3.58
Reference
4.78
3.71 to 6.15
No diabetes
Type 2 diabetes
Reference
3.72
1.77 to 7.82
Reference
3.30
1.48 to 7.34
No alcohol
consumption
Alcohol consumption
Reference
1.05
0.77 to 1.44
No abdominal obesity
Abdominal obesity
Reference
27.04
16.43 to 44.49
Associations were studied using stepwise logistic regression and
expressed as odds ratios (ORs) with 95% confidence intervals (CIs).
The variance is expressed as R2. Odds ratios were standardized
(SD) in the strata of ethnicity and sex per 1 SD unit variance for the
continuous independent variables.
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Studies of the Pima Indians, a population that shares
similarities with Iraqis in that they are highly insulin resistant
and have one of the highest prevalence rates of type 2 diabetes
in the world, have shown that increased lipid content in theFig. 2 – Correlation between fatty liver index (FLI) and insulin sen
abdominal obesity who were born in Iraq or Sweden. The assoc
birth (Pinteraction = 0.019), indicating that fatty liver disease may 
Swedes.liver independently links hypoadiponectinaemia, hypertro-
phic obesity and increased visceral adiposity with peripheral
and hepatic insulin resistance [27]. These findings are
consistent with our finding that type 2 diabetes and abdominal
obesity increased the odds of NAFLD (FLI  70). Our findings
that being born in Iraq was an independent risk factor for
NAFLD together with the finding that country of birth modified
the effect of FLI  70 on insulin action, suggests that NAFLD
has a potentially crucial role in the development of type 2
diabetes in Iraqis, representing the largest non-European
immigrant group in Sweden. Our data further suggests that
the Iraqi population with NAFLD is younger than the Swedish
born population. This may reflect an earlier onset of disturbed
fat metabolism contributing to insulin resistance and an
earlier diabetes onset in Iraqi immigrants that we have
previously reported [28].
Increased knowledge of the mechanisms triggering
insulin action in different populations is important for
better understanding in this high risk population for type 2
diabetes.
To our knowledge, there is a dearth of data on NAFLD from
Iraq. However, our data of an estimated prevalence of NAFLD
of over 30% in this population correspond with previous
studies conducted in the Middle East region. For instance a
comparison between populations of Arabs and South Asians
in Kuwait revealed a prevalence of NAFLD in 33.3 and 29.0%,
respectively [29] whereas the prevalence of NAFLD in Israelis
was reported to 30% [30] in both studies NAFLD was verified by
abdominal ultrasonography. Further ethnic as well as gender
differences in the prevalence of NAFLD is reported in studies of
Blacks, Hispanics and Whites conducted in the USA, with a
higher prevalence in Hispanics than in Blacks and a higher
prevalence in men than in women [14,29,30]. The latter issitivity index (ISI, log-transformed) in participants without
iation between ISI and FLI I70 was modified by country of
have a stronger impact on insulin action in Iraqis than in
Table 2b – Risk factors associated with insulin sensitivity index (log-transformed) in the total study population.
Variable Model 1
R2 = 0.09
b
95% CI
Model 2
R2 = 0.10
b
95% CI
Model 3
R2 = 0.13
b
95% CI
Model 4
R2 = 0.34
b
95% CI
Model 5
R2 = 0.35
b
95% CI
Born in Sweden
Born in Iraq
Reference
.12
.15 to .10
Reference
.13
.14 to .09
Reference
.12
.15 to .10
Reference
.09
.11 to .07
Reference
.11
.13 to .08
Age (years), per 1 SD .02
.04 to .01
.02
.03 to .01
.03
.04 to .01
.01
.02 to .01
.01
.02 to .01
Female sex
Male sex
Reference
.10
.12 to .07
Reference
.10
.13 to .08
Reference
.10
.13 to .08
Reference
.08
.11 to .06
Reference
.08
.11 to .06
No family history of diabetes
Family history of diabetes
Reference
.04
.07 to .02
Reference
.04
.07 to .02
Reference
.02
.04 to .01
Reference
.02
.04 to .01
Physical activity (h/week), per 1 SD .04
.03 to .06
.03
.02 to .04
.03
.02 to .04
No abdominal obesity
Abdominal obesity
Reference
.14
.17 to .12
Reference
.14
.17 to .11
No type 2 diabetes
Type 2 diabetes
Reference
.14
.22 to .06
Reference
.14
.22 to .06
Fatty liver index <70
Fatty liver index 70
Reference
.19
.22 to .16
Reference
.24
.28 to .19
Born in Iraq  Fatty liver index 70 .06
.01 to .12
Associations were studied using stepwise linear regression and are expressed as b coefficients with 95% confidence intervals (CIs). The
variance is expressed as R2. b-coefficients were standardized (SD) in the strata of ethnicity and sex per 1 SD unit variance for the continuous
independent variables. Variance inflation factor (VIF) <3.8. Numbers highlighted in bold are statistically significant.
d i a b e t e s r e s e a r c h a n d c l i n i c a l p r a c t i c e 1 1 0 ( 2 0 1 5 ) 6 6 – 7 472consistent with our data showing higher odds of FLI 70 in
men than in women, irrespective of abdominal obesity or
other risk factors for NAFLD. A higher prevalence of NAFLD in
different populations could also be caused by genetics. For
instance, NAFLD shares genetic risk factors with other
intermediate metabolic risk factors such as diminished insulin
sensitivity and hypertriglyceridemia [20] and genetic factors is
shown to contribute to disturbed fat metabolism and
increased fat storage in the liver, causing steatohepatosis
and subsequently fibrosis [3].
5.3. Strengths and limitations
Our study is population-based and represents a large fraction
of the Iraqi population in the studied region. It is also distinct
from other studies of this topic in that it includes detailed
metabolic phenotyping and assessments of lifestyle expo-
sures. The study is limited by the inability to infer causality
due to the cross-sectional design. The participating Swedes
were somewhat older than the corresponding native Swedish
background population, which may have introduced selection
bias. However, we consider our data reliable since age is
adjusted for in the multivariate regression models. FLI or other
estimations of NAFLD have been developed in a Caucasian
population and has not been studied or validated before in
Middle Eastern populations. Another limitation is that the
study lacks quantitative information on liver fat content
assessed by abdominal ultrasound or magnetic resonance
imaging (MRI).6. Conclusions
This study reports that irrespective of traditional risk factors,
immigrants from Iraq have a higher probability of NAFLD and
worse insulin action than native Swedes. Although liver fat
content was not investigated by ultrasound or MRI in the
present study, our data indicate that Iraqis and in particular
Iraqi males have a very high probability of NAFLD, and that this
probability increases further in those with abdominal obesity.
Our data suggests that liver fat content may play a stronger role
in insulin action in the Iraqi compared to the Swedish
population. Population-based focused on objectively verifying
liver fat content and studying the influence of NAFLD on type 2
diabetes risk in Middle Eastern populations may be warranted.
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